New Combinations with Herceptin^® in Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|61|2|50-57

ISSN： 0030-2414

Source： Oncology, Vol.61, Iss.2, 2001-10, pp. : 50-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First-Line Herceptin^® Monotherapy in Metastatic Breast Cancer

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 37-42

Karger

Access to resources Recommend Favorite

New indication for Herceptin in early stage breast cancer

Personalized Medicine, Vol. 2, Iss. 2, 2005-05 ,pp. : 89-92

Future Medicine

Access to resources Recommend Favorite

Retrospective Analysis of the Safety of Herceptin^® Immunotherapy in Metastatic Breast Cancer

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 58-66

Karger

Access to resources Recommend Favorite

What Can We Learn from Herceptin^® Trials in Metastatic Breast Cancer?

Oncology, Vol. 63, Iss. 1, 2002-11 ,pp. : 39-46

Karger

Access to resources Recommend Favorite

Herceptin^® Alone or in Combination with Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Pivotal Trials

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 14-21

Karger

Access to resources Recommend Favorite